Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dora Čerina

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cancers|February 24, 2024
Prognostic Value of Apparent Diffusion Coefficient (ADC) in Patients with Diffuse GliomasMarija Bušić, Zoran Rumboldt, Dora Čerina, et al.
Current Oncology (Toronto, Ont.)|July 27, 2022
Is There a Place for Adjuvant Chemotherapy in the Treatment of Locally Advanced Cervical Cancer?Dora Čerina, Tihana Boraska Jelavić, Matea Buljubašić Franić, et al.
Cell Host & Microbe|March 31, 2026
The DanRI regulatory system in uropathogenic Escherichia coli subverts neutrophil responsesDora Čerina, Matthieu Rousseau, Carla Hart Olaiz, et al.
Journal of Personalized Medicine|July 27, 2022
Comprehensive Genomic Profiling in the Management of Ovarian Cancer-National Results from CroatiaDora Čerina, Višnja Matković, Kristina Katić, et al.
The Oncologist|March 28, 2025
Dynamics of hyperglycemia of patients treated with alpelisib: exploratory interim analysis of ITACA trialMarija Pancirov, Josipa Flam, Jelena Šuto Pavičić, et al.
The Breast Journal|January 1, 2025
Associations between PIK3CA Mutations and Disease Free Survival in Patients with HR+, HER2- Tumors Treated with Adjuvant Hormonal Therapy: A Real-World Study in CroatiaDora Čerina Pavlinović, Natalija Dedić Plavetić, Ingrid Belac Lovasić, et al.
Cancers|July 12, 2025
Efficacy of Dual Hormonal Therapy with Fulvestrant and Aromatase Inhibitors as Neoadjuvant Endocrine Treatment for Locally Advanced Breast CancerAna Majić, Žarko Bajić, Marija Ban, et al.
Pathology Oncology Research : POR|October 14, 2021
Precision Oncology in Metastatic Uterine Cancer; Croatian First-Year Experience of the Comprehensive Genomic Profiling in Everyday Clinical PracticeDora Čerina, Višnja Matković, Kristina Katić, et al.
Journal of Personalized Medicine|February 25, 2025
Precision Oncology in Clinical Practice: Two Years of Comprehensive Genomic Profiling in CroatiaDora Čerina Pavlinović, Jelena Šuto Pavičić, Antonela Njavro, et al.
Cancers|April 14, 2026
Impact of Time of Administration, Fasting, and a Low-Carbohydrate Diet on Alpelisib-Associated Hyperglycemia and Efficacy: A Pilot Randomized Controlled Phase IIb TrialEduard Vrdoljak, Marija Pancirov, Josipa Flam, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cancers|February 24, 2024
Prognostic Value of Apparent Diffusion Coefficient (ADC) in Patients with Diffuse GliomasMarija Bušić, Zoran Rumboldt, Dora Čerina, et al.
Current Oncology (Toronto, Ont.)|July 27, 2022
Is There a Place for Adjuvant Chemotherapy in the Treatment of Locally Advanced Cervical Cancer?Dora Čerina, Tihana Boraska Jelavić, Matea Buljubašić Franić, et al.
Cell Host & Microbe|March 31, 2026
The DanRI regulatory system in uropathogenic Escherichia coli subverts neutrophil responsesDora Čerina, Matthieu Rousseau, Carla Hart Olaiz, et al.
Journal of Personalized Medicine|July 27, 2022
Comprehensive Genomic Profiling in the Management of Ovarian Cancer-National Results from CroatiaDora Čerina, Višnja Matković, Kristina Katić, et al.
The Oncologist|March 28, 2025
Dynamics of hyperglycemia of patients treated with alpelisib: exploratory interim analysis of ITACA trialMarija Pancirov, Josipa Flam, Jelena Šuto Pavičić, et al.
The Breast Journal|January 1, 2025
Associations between PIK3CA Mutations and Disease Free Survival in Patients with HR+, HER2- Tumors Treated with Adjuvant Hormonal Therapy: A Real-World Study in CroatiaDora Čerina Pavlinović, Natalija Dedić Plavetić, Ingrid Belac Lovasić, et al.
Cancers|July 12, 2025
Efficacy of Dual Hormonal Therapy with Fulvestrant and Aromatase Inhibitors as Neoadjuvant Endocrine Treatment for Locally Advanced Breast CancerAna Majić, Žarko Bajić, Marija Ban, et al.
Pathology Oncology Research : POR|October 14, 2021
Precision Oncology in Metastatic Uterine Cancer; Croatian First-Year Experience of the Comprehensive Genomic Profiling in Everyday Clinical PracticeDora Čerina, Višnja Matković, Kristina Katić, et al.
Journal of Personalized Medicine|February 25, 2025
Precision Oncology in Clinical Practice: Two Years of Comprehensive Genomic Profiling in CroatiaDora Čerina Pavlinović, Jelena Šuto Pavičić, Antonela Njavro, et al.
Cancers|April 14, 2026
Impact of Time of Administration, Fasting, and a Low-Carbohydrate Diet on Alpelisib-Associated Hyperglycemia and Efficacy: A Pilot Randomized Controlled Phase IIb TrialEduard Vrdoljak, Marija Pancirov, Josipa Flam, et al.
Pageof 2